Cargando…

Prognostication in Different Heart Failure Phenotypes: The Role of Circulating Biomarkers

Heart failure (HF) is multifactorial syndrome with high cardiovascular (CV) morbidity and mortality rates associated with an increasing prevalence worldwide. Measuring plasma levels of circulating biomarkers, i.e., natriuretic peptides, cardiac-specific troponins, metabolomic intermediates, Galectin...

Descripción completa

Detalles Bibliográficos
Autor principal:	Berezin, Alexander E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548324/ https://www.ncbi.nlm.nih.gov/pubmed/28936254 http://dx.doi.org/10.5772/62797

Ejemplares similares

Epigenetics in heart failure phenotypes()
por: Berezin, Alexander
Publicado: (2016)

Editorial: Prognostication of Heart Failure Evolution: From Circulating Biomarkers to Genetic Risk Predictive Score
por: Berezin, Alexander E., et al.
Publicado: (2021)

Biomarkers in Heart Failure: From Research to Clinical Practice
por: Berezin, Alexander E., et al.
Publicado: (2023)

The predictive role of circulating microparticles in patients with chronic heart failure()
por: Berezin, Alexander E., et al.
Publicado: (2014)

Myokines and Heart Failure: Challenging Role in Adverse Cardiac Remodeling, Myopathy, and Clinical Outcomes
por: Berezin, Alexander E., et al.
Publicado: (2021)

Discriminative Value of Serum Irisin in Prediction of Heart Failure with Different Phenotypes among Patients with Type 2 Diabetes Mellitus
por: Berezin, Alexander A., et al.
Publicado: (2022)

The signature of circulating microparticles in heart failure patients with metabolic syndrome
por: Berezin, Alexander E, et al.
Publicado: (2016)

Predictive value of circulating osteonectin in patients with ischemic symptomatic chronic heart failure
por: Berezin, Alexander E., et al.
Publicado: (2015)

Circulating Cardiac Biomarkers in Diabetes Mellitus: A New Dawn for Risk Stratification—A Narrative Review
por: Berezin, Alexander E., et al.
Publicado: (2020)

Extracellular Endothelial Cell-Derived Vesicles: Emerging Role in Cardiac and Vascular Remodeling in Heart Failure
por: Berezin, Alexander E., et al.
Publicado: (2020)

Circulating thrombospondin-2 in patients with moderate-to-severe chronic heart failure due to coronary artery disease
por: Berezin, Alexander E., et al.
Publicado: (2016)

Emerging Role of Adipocyte Dysfunction in Inducing Heart Failure Among Obese Patients With Prediabetes and Known Diabetes Mellitus
por: Berezin, Alexander E., et al.
Publicado: (2020)

Pattern of circulating microparticles in chronic heart failure patients with metabolic syndrome: Relevance to neurohumoral and inflammatory activation
por: Berezin, Alexander E., et al.
Publicado: (2015)

The utility of biomarker risk prediction score in patients with chronic heart failure
por: Berezin, Alexander E., et al.
Publicado: (2016)

The Association of Subclinical Hypothyroidism and Pattern of Circulating Endothelial-Derived Microparticles Among Chronic Heart Failure Patients
por: Berezin, Alexander E., et al.
Publicado: (2015)

Serum Uric Acid Predicts Declining of Circulating Proangiogenic Mononuclear Progenitor Cells in Chronic Heart Failure Patients
por: Berezin, Alexander E., et al.
Publicado: (2014)

Circulating Endothelial-Derived Apoptotic Microparticles in the Patients with Ischemic Symptomatic Chronic Heart Failure: Relevance of Pro-Inflammatory Activation and Outcomes
por: Berezin, Alexander E., et al.
Publicado: (2014)

Low Plasma Levels of Irisin Predict Acutely Decompensated Heart Failure in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure
por: Berezin, Alexander A., et al.
Publicado: (2023)

Sex differences in ischemic heart disease and heart failure biomarkers
por: Sobhani, Kimia, et al.
Publicado: (2018)

The Effect of SGLT2 Inhibitor Dapagliflozin on Serum Levels of Apelin in T2DM Patients with Heart Failure
por: Berezin, Alexander A., et al.
Publicado: (2022)

Editorial: Acute heart failure: From bench to bedside
por: Berezin, Alexander E., et al.
Publicado: (2023)

Adverse Cardiac Remodelling after Acute Myocardial Infarction: Old and New Biomarkers
por: Berezin, Alexander E., et al.
Publicado: (2020)

Sirt1 Activity in PBMCs as a Biomarker of Different Heart Failure Phenotypes
por: Conti, Valeria, et al.
Publicado: (2020)

Predictive value of serum irisin for chronic heart failure in patients with type 2 diabetes mellitus
por: Berezin, Alexander A., et al.
Publicado: (2022)

Editorial: Epigenetics in Heart Failure Developing: The Orchestra of Etiology and Comorbidities
por: Berezin, Alexander E., et al.
Publicado: (2022)

Circulating Circular RNAs: Novel Biomarkers for Heart Failure
por: Sun, Chuan, et al.
Publicado: (2020)

Systemic Biomarkers and Unique Pathways in Different Phenotypes of Heart Failure with Preserved Ejection Fraction
por: Chen, Hao, et al.
Publicado: (2022)

Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC)
por: Meijers, Wouter C., et al.
Publicado: (2021)

Prognostic Role of Metabolic Exercise Testing in Heart Failure
por: Agdamag, Arianne Clare, et al.
Publicado: (2023)

Different heart failure phenotypes of valvular heart disease: the role of mitochondrial dysfunction
por: Zhang, Shenghui, et al.
Publicado: (2023)

The Utility of Circulating and Imaging Biomarkers Alone and in Combination in Heart Failure
por: Jaltotage, Biyanka, et al.
Publicado: (2021)

Interplay between Myokine Profile and Glycemic Control in Type 2 Diabetes Mellitus Patients with Heart Failure
por: Berezin, Alexander A., et al.
Publicado: (2022)

Adropin Predicts Chronic Kidney Disease in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure
por: Berezina, Tetiana A., et al.
Publicado: (2023)

Discriminative Utility of Apelin-to-NT-Pro-Brain Natriuretic Peptide Ratio for Heart Failure with Preserved Ejection Fraction among Type 2 Diabetes Mellitus Patients
por: Berezin, Alexander A., et al.
Publicado: (2022)

Multidimensional Approach of Heart Failure Diagnosis and Prognostication Utilizing Cardiac Imaging with Biomarkers
por: Kim, In-Cheol, et al.
Publicado: (2022)

Serum Levels of Irisin Predict Cumulative Clinical Outcomes in Heart Failure Patients With Type 2 Diabetes Mellitus
por: Berezin, Alexander A., et al.
Publicado: (2022)

Prognostic Value of Multiple Circulating Biomarkers for 2-Year Death in Acute Heart Failure With Preserved Ejection Fraction
por: Gao, Yan, et al.
Publicado: (2021)

Circulating miR‐19b‐3p as a Novel Prognostic Biomarker for Acute Heart Failure
por: Su, Yang, et al.
Publicado: (2021)

Circulating tumor cells in thyroid carcinoma - the prognostic role of this biomarker. Review of the literature
por: BĂDULESCU, IULIAN CLAUDIU, et al.
Publicado: (2017)

The Role of Congestion Biomarkers in Heart Failure with Reduced Ejection Fraction
por: Correale, Michele, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r9alerj8doleb7l6knmkhu72km